HARBOUR INVESTMENTS, INC.

Position in NTLA — Intellia Therapeutics, Inc.

CIK 810121 MADISON, WI

Position in NTLA

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$127,475

+$33,261 QoQ

Shares Held

7,534

+2.5% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#228

of 323 holders

Holding Since

Mar 2021

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HARBOUR INVESTMENTS, INC. holds $3,691,310 across 132 Biotechnology names. NTLA ranks #8 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	16,451	$641,753
2	REGN	Regeneron Pharmaceuticals, Inc.	636	$396,571
3	VRTX	Vertex Pharmaceuticals Inc / Ma	734	$364,599
4	JAZZ	Jazz Pharmaceuticals plc	1,365	$328,924
5	OMER	Omeros Corp	23,139	$220,051
6	CRSP	CRISPR Therapeutics AG	3,533	$192,689
7	STOK	Stoke Therapeutics, Inc.	4,413	$144,393
8	NTLA	Intellia Therapeutics, Inc. This page	7,534	$127,475

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$127,475	7,534	+2.5%	Shares	Sole	2026-08-12
2026-03-31	$94,214	7,349	+7.7%	Shares	Sole	2026-05-15
2025-12-31	$61,356	6,825	+4.1%	Shares	Sole	2026-02-09
2025-09-30	$113,222	6,556	-1.2%	Shares	Sole	2025-11-12
2025-06-30	$62,217	6,633	+27.2%	Shares	Sole	2025-07-28
2025-03-31	$37,071	5,214	+76.7%	Shares	Sole	2025-05-08
2024-12-31	$34,397	2,950	+36.2%	Shares	Sole	2025-02-10
2024-09-30	$44,511	2,166	+26.6%	Shares	Sole	2024-11-04
2024-06-30	$38,292	1,711	+5.3%	Shares	Sole	2024-07-26
2024-03-31	$44,703	1,625	+112.7%	Shares	Sole	2024-07-22
2023-12-31	$23,294	764	+1676.7%	Shares	Sole	2024-02-16
2021-12-31	$5,084	43	-30.6%	Shares	Sole	2022-02-16
2021-09-30	$8,317	62	+17.0%	Shares	Sole	2021-11-15
2021-06-30	$8,581	53	+65.6%	Shares	Sole	2021-08-16
2021-03-31	$2,568	32	—	Shares	Sole	2021-08-17
No filing history on record for this holder in this stock.